PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

MLM announces new executive leadership – Scott Houlton named CEO and Roger Gasper CFO

Moenchengladbach, GERMANY; MEMPHIS, TN; MINNEAPOLIS, MN — MLM Medical Labs (“MLM”) is pleased to announce that Scott Houlton has joined the company as the new Chief Executive Officer and Roger Gasper as the Chief Financial Officer.  Mr. Houlton brings over 25 years of life sciences experience to MLM. Most recently Mr. Houlton served as CEO of Clinical Supplies Management, Inc. (“CSM”), which specialized in managing global clinical trials for biotech and pharmaceutical companies. CSM was a previous portfolio company of Great Point Partners (“GPP”) who is the lead investor in MLM. CSM successfully integrated three international clinical supply companies and achieved significant growth before being acquired by Clinigen Group, based in the United Kingdom.  Prior to CSM, Mr. Houlton was President at Catalent, Chief Operating Officer at Aptuit, Inc. and held leadership positions at Quintiles and Cardinal Health. 

“I am excited to join the talented team at MLM and look forward to helping grow the business now that MLM has acquired two specialty labs in the US with CirQuest Labs and MD Biosciences.  The specialty and safety lab testing that MLM now offers in both the US and Europe provides our customers the scientific expertise they need with the flexible, high-touch customer service that is often missing from the large laboratories,” stated Mr. Houlton.

MLM also announced that Roger Gasper has been named Chief Financial Officer.  Mr. Gasper has an established track record in both private and public companies.  Most recently Mr. Gasper served as CFO at MaSTherCell Global, a leading cell and gene therapy contract development and manufacturing partner recently acquired by Catalent.  Prior to MaSTherCell (also a GPP portfolio company), Mr. Gasper worked with Mr. Houlton as CFO at CSM and was previously CFO at The J.G. Wentworth Company.

“We are fortunate to be able to work with both Scott and Roger again with MLM after having achieved great results together in our previous investments in both CSM and MaSTherCell”, said Mr. Rohan Saikia, Managing Director at Great Point Partners.  “GPP has already supported MLM with two tuck-in acquisitions in the US and we look forward to the continued growth of MLM.  We would like to thank Dr. Stephan Wnendt for his success in building MLM and his partnership with GPP.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026